{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:38:23Z","timestamp":1761835103059,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:00:00Z","timestamp":1518566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.tranon.2018.02.021","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T23:49:25Z","timestamp":1522367365000},"page":"647-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Combined Selection System to Lower the Cutoff for Plasma Cell Enrichment Applied to iFISH Analysis in Multiple Myeloma"],"prefix":"10.1016","volume":"11","author":[{"given":"Cristina","family":"Mansilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miren","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Valiente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ar\u00e1nzazu","family":"Perez-Juana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaya","family":"Zabalza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermina","family":"Hurtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Sala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2018.02.021_bb0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.tranon.2018.02.021_bb0010","first-page":"13","article-title":"IgM myeloma: 6 cases and a review of the literature","volume":"11","author":"De Gramont","year":"1990","journal-title":"Rev Med Interne"},{"issue":"3","key":"10.1016\/j.tranon.2018.02.021_bb0015","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00277-001-0420-9","article-title":"IgM myeloma: a report of four cases","volume":"81","author":"Dierlamm","year":"2002","journal-title":"Ann Hematol"},{"issue":"8","key":"10.1016\/j.tranon.2018.02.021_bb0020","first-page":"798","article-title":"Unusual myelomas: a review of IgD and IgE variants","volume":"27","author":"Pandey","year":"2013","journal-title":"Oncology (Williston Park)"},{"issue":"6","key":"10.1016\/j.tranon.2018.02.021_bb0025","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1309\/5KWKP6UKGNXXHMYH","article-title":"Frequent gains of the short arm of chromosome 9 in multiple myeloma with normal G-banded karyotype detected by comparative genomic hybridization","volume":"122","author":"Tchinda","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.tranon.2018.02.021_bb0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1157\/13107365","article-title":"Multiple myeloma","volume":"129","author":"Garc\u00eda-Sanz","year":"2007","journal-title":"Med Clin (Barc)"},{"issue":"1","key":"10.1016\/j.tranon.2018.02.021_bb0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2013.12.015","article-title":"Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy","volume":"25","author":"Lohr","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tranon.2018.02.021_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3997","article-title":"Heterogeneity of genomic evolution and mutational profiles in multiple myeloma","volume":"5","author":"Bolli","year":"2014","journal-title":"Nat Commun"},{"issue":"33","key":"10.1016\/j.tranon.2018.02.021_bb0045","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1200\/JCO.2014.59.1503","article-title":"Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma","volume":"33","author":"Walker","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tranon.2018.02.021_bb0050","first-page":"1","article-title":"Utilizing next-generation sequencing in the management of multiple myeloma","author":"Lionetti","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"issue":"5","key":"10.1016\/j.tranon.2018.02.021_bb0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/mp.55.5.273","article-title":"Molecular aspects of multiple myeloma","volume":"55","author":"Pratt","year":"2002","journal-title":"Mol Pathol"},{"issue":"4","key":"10.1016\/j.tranon.2018.02.021_bb0060","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1200\/JCO.2000.18.4.804","article-title":"Predictive role of interphase cytogenetics for survival of patients with multiple myeloma","volume":"18","author":"K\u00f6nigsberg","year":"2000","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.tranon.2018.02.021_bb0065","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1182\/blood.V99.10.3735","article-title":"Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients","volume":"99","author":"Fonseca","year":"2002","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.tranon.2018.02.021_bb0070","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/leu.2015.209","article-title":"Defining and treating high-risk multiple myeloma","volume":"29","author":"Usmani","year":"2015","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.tranon.2018.02.021_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrc746","article-title":"Multiple myeloma: evolving genetic events and host interactions","volume":"2","author":"Kuehl","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.tranon.2018.02.021_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2012.37","article-title":"The t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies","volume":"2","author":"Kalff","year":"2012","journal-title":"Blood Cancer J"},{"issue":"2","key":"10.1016\/j.tranon.2018.02.021_bb0085","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3109\/10428194.2010.537795","article-title":"Clinical and biological features of t(4;14) multiple myeloma: a prospective study","volume":"52","author":"Karlin","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.tranon.2018.02.021_bb0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11899-017-0368-z","article-title":"Current Review on High-Risk Multiple Myeloma","volume":"12","author":"Chan","year":"2017","journal-title":"Curr Hematol Malig Rep"},{"issue":"2A","key":"10.1016\/j.tranon.2018.02.021_bb0095","first-page":"953","article-title":"Chromosome 1 abnormalities in multiple myeloma","volume":"26","author":"Marzin","year":"2006","journal-title":"Anticancer Res"},{"issue":"1\u20132","key":"10.1016\/j.tranon.2018.02.021_bb0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10428199609054799","article-title":"DNA cell content studies in multiple myeloma","volume":"23","author":"San Miguel","year":"1996","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.tranon.2018.02.021_bb0105","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1182\/blood.V91.9.3366","article-title":"Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes","volume":"91","author":"P\u00e9rez-Sim\u00f3n","year":"1998","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.tranon.2018.02.021_bb0110","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3324\/haematol.2011.056176","article-title":"Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders","volume":"97","author":"Ross","year":"2012","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.tranon.2018.02.021_bb0115","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"18","key":"10.1016\/j.tranon.2018.02.021_bb0120","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2010-10-299529","article-title":"Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3","volume":"117","author":"Dimopoulos","year":"2011","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.tranon.2018.02.021_bb0125","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"van Dongen","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.tranon.2018.02.021_bb0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.beha.2010.09.002","article-title":"Immunophenotyping in multiple myeloma and related plasma cell disorders","volume":"23","author":"Kumar","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"issue":"22","key":"10.1016\/j.tranon.2018.02.021_bb0135","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.tranon.2018.02.021_bb0140","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","article-title":"A monoclonal gammopathy precedes multiple myeloma in most patients","volume":"113","author":"Weiss","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.tranon.2018.02.021_bb0145","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1182\/blood.V96.6.2037","article-title":"Solitary plasmacytoma of bone and asymptomatic multiple myeloma","volume":"96","author":"Dimopoulos","year":"2000","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.tranon.2018.02.021_bb0150","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/blood-2007-05-088443","article-title":"New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells","volume":"110","author":"P\u00e9rez-Persona","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.tranon.2018.02.021_bb0155","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1200\/JCO.2009.25.2114","article-title":"Survival and years of life lost in different age cohorts of patients with multiple myeloma","volume":"28","author":"Ludwig","year":"2010","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.tranon.2018.02.021_bb0160","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3324\/haematol.2009.009100","article-title":"Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients","volume":"94","author":"Paiva","year":"2009","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.tranon.2018.02.021_bb0165","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","article-title":"Genetics and cytogenetics of multiple myeloma: a workshop report","volume":"64","author":"Fonseca","year":"2004","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.tranon.2018.02.021_bb0170","doi-asserted-by":"crossref","first-page":"E473","DOI":"10.1002\/ajh.24533","article-title":"Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma","volume":"91","author":"Merz","year":"2016","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.tranon.2018.02.021_bb0175","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/cncr.25775","article-title":"Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone","volume":"117","author":"Klein","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2018.02.021_bb0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00277-012-1566-3","article-title":"The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myeloma","volume":"92","author":"Puig","year":"2013","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.tranon.2018.02.021_bb0185","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12185-010-0651-4","article-title":"Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sorting","volume":"92","author":"Cumova","year":"2010","journal-title":"Int J Hematol"},{"issue":"10","key":"10.1016\/j.tranon.2018.02.021_bb0190","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3324\/haematol.2014.103853","article-title":"Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies","volume":"99","author":"Caltagirone","year":"2014","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.tranon.2018.02.021_bb0195","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/sj.leu.2401041","article-title":"Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases","volume":"12","author":"Smadja","year":"1998","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.tranon.2018.02.021_bb0200","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2005-01-0034","article-title":"Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma","volume":"106","author":"Bergsagel","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.tranon.2018.02.021_bb0205","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2005-02-0761","article-title":"A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS","volume":"106","author":"Chng","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.tranon.2018.02.021_bb0210","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/gcc.22074","article-title":"Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma","volume":"52","author":"Alpar","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.tranon.2018.02.021_bb0215","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrclinonc.2016.122","article-title":"Genomic complexity of multiple myeloma and its clinical implications","volume":"14","author":"Manier","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.tranon.2018.02.021_bb0220","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/leu.2017.179","article-title":"Prediction of outcome in newly diagnosed myeloma: A meta-analysis of the molecular profiles of 1,905 trial patients","volume":"32","author":"Shah","year":"2018","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.tranon.2018.02.021_bb0225","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12185-013-1291-2","article-title":"Molecular pathogenesis of multiple myeloma: basic and clinical updates","volume":"97","author":"Chesi","year":"2013","journal-title":"Int J Hematol"},{"issue":"9","key":"10.1016\/j.tranon.2018.02.021_bb0230","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.leu.2403857","article-title":"Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma","volume":"19","author":"Ross","year":"2005","journal-title":"Leukemia"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523317304047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523317304047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:33:30Z","timestamp":1761834810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523317304047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1936523317304047"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2018.02.021","relation":{},"ISSN":["1936-5233"],"issn-type":[{"type":"print","value":"1936-5233"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined Selection System to Lower the Cutoff for Plasma Cell Enrichment Applied to iFISH Analysis in Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2018.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. <!Employer>Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}]}}